Brokerages predict that HealthStream, Inc. (NASDAQ:HSTM) will post $62.63 million in sales for the current quarter, according to Zacks. Five analysts have provided estimates for HealthStream’s earnings. The lowest sales estimate is $62.28 million and the highest is $62.90 million. HealthStream reported sales of $58.37 million during the same quarter last year, which would suggest a positive year over year growth rate of 7.3%. The business is expected to issue its next earnings report on Wednesday, November 1st.

On average, analysts expect that HealthStream will report full year sales of $62.63 million for the current year, with estimates ranging from $246.23 million to $248.15 million. For the next fiscal year, analysts anticipate that the company will post sales of $270.95 million per share, with estimates ranging from $269.74 million to $272.62 million. Zacks’ sales averages are a mean average based on a survey of research analysts that follow HealthStream.

HealthStream (NASDAQ:HSTM) last announced its earnings results on Monday, July 24th. The technology company reported $0.08 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.04 by $0.04. HealthStream had a net margin of 1.85% and a return on equity of 2.27%. The business had revenue of $61.48 million during the quarter, compared to analysts’ expectations of $61.36 million. During the same quarter in the prior year, the company posted $0.04 earnings per share. The firm’s revenue was up 12.2% on a year-over-year basis.

Several research firms recently issued reports on HSTM. Needham & Company LLC reduced their price target on shares of HealthStream from $32.00 to $26.00 and set a “buy” rating for the company in a research report on Wednesday, July 26th. Canaccord Genuity reissued a “hold” rating and issued a $25.00 price target on shares of HealthStream in a research report on Thursday, July 27th. Robert W. Baird reissued a “buy” rating and issued a $30.00 price target on shares of HealthStream in a research report on Thursday, August 31st. First Analysis raised shares of HealthStream from an “underweight” rating to an “equal weight” rating and set a $19.00 price target for the company in a research report on Wednesday, July 26th. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $24.00 price target (down previously from $28.00) on shares of HealthStream in a research report on Wednesday, July 26th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the stock. HealthStream presently has an average rating of “Hold” and a consensus price target of $25.17.

Institutional investors and hedge funds have recently bought and sold shares of the business. Teachers Advisors LLC boosted its holdings in HealthStream by 0.3% during the 1st quarter. Teachers Advisors LLC now owns 333,482 shares of the technology company’s stock worth $8,080,000 after acquiring an additional 1,052 shares during the last quarter. Blair William & Co. IL boosted its holdings in shares of HealthStream by 2.6% in the 2nd quarter. Blair William & Co. IL now owns 71,050 shares of the technology company’s stock worth $1,870,000 after buying an additional 1,795 shares during the last quarter. Comerica Bank boosted its holdings in shares of HealthStream by 3.9% in the 1st quarter. Comerica Bank now owns 28,062 shares of the technology company’s stock worth $812,000 after buying an additional 1,049 shares during the last quarter. Schwab Charles Investment Management Inc. boosted its holdings in shares of HealthStream by 5.2% in the 1st quarter. Schwab Charles Investment Management Inc. now owns 107,018 shares of the technology company’s stock worth $2,594,000 after buying an additional 5,277 shares during the last quarter. Finally, Bank of America Corp DE boosted its holdings in shares of HealthStream by 27.2% in the 1st quarter. Bank of America Corp DE now owns 234,618 shares of the technology company’s stock worth $5,685,000 after buying an additional 50,163 shares during the last quarter. 75.87% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: This news story was first published by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of U.S. & international copyright legislation. The original version of this news story can be viewed at https://www.americanbankingnews.com/2017/10/12/62-63-million-in-sales-expected-for-healthstream-inc-hstm-this-quarter-2.html.

Shares of HealthStream (NASDAQ HSTM) traded up 0.020% on Thursday, reaching $24.505. 7,212 shares of the company traded hands. HealthStream has a one year low of $20.60 and a one year high of $31.53. The company has a market capitalization of $781.37 million, a PE ratio of 176.295 and a beta of 0.98. The firm has a 50-day moving average price of $23.50 and a 200 day moving average price of $25.46.

About HealthStream

HealthStream, Inc (HealthStream) provides workforce, patient experience and provider solutions for healthcare organizations. The Company operates in three segments: HealthStream Workforce Solutions, HealthStream Patient Experience Solutions and HealthStream Provider Solutions. HealthStream’s products and services are organized into three segments: Workforce Solutions, Patient Experience Solutions, and Provider Solutions.

Get a free copy of the Zacks research report on HealthStream (HSTM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HealthStream (NASDAQ:HSTM)

Receive News & Ratings for HealthStream Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream Inc. and related companies with MarketBeat.com's FREE daily email newsletter.